A Pharm-Olam Center of Excellence with Proven Expertise to Help You Create a Healthier World
As an Infectious Disease and Vaccine focused CRO we understand that no matter your size, resources are limited, drug development is costly and time to market is precious. We share your goals of bringing new treatments to market and recognize that milestones in the performance of your trials are critical, potentially enabling you to secure your next round of funding and continue your development program.
What is a Center of Excellence?
Pharm-Olam created three Centers of Excellence (Infectious Disease and Vaccines, Rare Disease and Oncology-Hematology). Our "centers" are purpose-built to increase efficiency and delivery to timeline and budget. Each Center of Excellence brings together an ecosystem of cross-functional, therapeutically aligned teams that specialize in optimizing investigators, vendors and partners around the world to deliver your trial effectively and efficiently. Pharm-Olam has specifically invested in these three centers to drive true tangible value for our Sponsors and their studies.
Thisscalable delivery ecosystem/model(one of our pillars in thepattern of excellence) creates synergies and efficiencies that optimize how Pharm-Olam, investigators and vendors collaborate to provide enhanced solutions for expediting and completing your studies on time and on budget.
Expertise You Can Trust, Expertise That Delivers
Drug Approvals for Infectious Disease and Vaccine Products
% project managers with infectious disease and/or vaccine experience
% CRAs with infectious disease and/or vaccine experience
Infectious Disease and Vaccine Expertise
Expertise That Fits Your Clinical Trial
Because we have therapeutically aligned project teams, your clinical trial receives attention from experts who understand the unique needs of studies conducted in infectious disease and vaccines. We are not guessing how to support your sites and patients, we know how because of our experienced staff. At Pharm-Olam, 79% of our CRAs and 84% of our project managers have specialized infectious disease and vaccine experience. We are not only experts in our field, we are experts in your clinical trial.
Deep Roots in Antibiotic Research:
We have expansive infectious disease experience, but especially deep roots in supporting anti-infective development. Our long and successful history in the anti-infective area of drug development, is demonstrated by supporting more than50% of all antibiotics approved by FDA/EMA since 2010.
What’s more, we have executed numerous pivotal studies supporting marketing approvals for the following indications, to name a few:
3 compounds for acute bacterial skin and skin structure infections
3 compounds for pneumonia – community acquired and nosocomial (ventilator associated, and hospital acquired)
1 compound for Urinary tract infections
Scalable Delivery Ecosystem
A Flexible and Supportive Ecosystem for Infectious Disease and Vaccine Delivery
Your infectious disease and vaccine study needs are global and so is our delivery ecosystem. We have established strategic relationships around the world, building a network of partners and vendors to support your unique requirements for infectious disease and vaccine research, including:
Strategically advantageous site relationships and networks in emerging and developing countries in Africa, Asia and South America where research and population access is needed in specific indications delivered via our Expeditionary CRO services
Established networks in North America, Western, Central and Eastern Europe
Global ancillary vendor relationships critical to supporting sample collection, delivery and analysis.
Our work on this ecosystem is continuous and constantly expanding to ensure that you receive the most optimal delivery system for your infectious disease and vaccine studies. To learn more about our Expeditionary CRO capability to access Africa, Asia and South America, click the button below.
“Working with Pharm-Olam was an absolute pleasure. The entire team was very knowledgeable, professional and customer focused. They showed an excellent level of organization and were always on top of any issues.”
Biotech - Director ClinOps
U.S. Government Federal Research Services
Supporting Sponsors Seeking and Performing Government Funded Clinical Trials
For more than 20 years, we have been working directly with federal agencies, contracting and conducting federally funded drug and vaccine research.
Our team has collaborated with many U.S. government agencies, including the National Institutes of Health (NIH), U.S. Department of Defense (DOD), Biomedical Advanced Research and Development Authority (BARDA), Centers for Disease Control and Prevention (CDC), among others. We also have worked extensively with non-government organizations (NGOs) and nonprofit organizations.
To learn how we can support your program from both a pre-award and post-award capacity, click the button below to visit our U.S. Government Federal Research Services page.
Efficient Program Execution and Protocol Development
Conducting infectious disease and vaccine research is especially complicated. One incorrect end point can mean the difference between successfully meeting milestones or incurring costly delays and budget overages. That’s why we provide comprehensive program and protocol development consulting to ensure that your infectious disease and vaccine research is exceptionally well-planned and executed as efficiently as possible from day one.
When you work with our infectious disease and vaccines team, led by Dr. Slobodan Ilic, we review the development of your program across all functional areas to ensure the strictest adherence to protocol and regulatory requirements. In addition, Dr. Kelly McKee, whose infectious disease research career spans more than 40 years, is also available to oversee and consult on your development program.
Having our team of experts review and advise on your program and protocol development will streamline your project from beginning to end.
Powered by Medidata
Powerful Technology for Enhanced Data Visualization
Pharm-Olam is the only CRO in the industry to leverage the full power of Medidata's Unified Platform, the Medidata Rave® Clinical Cloud. As a benefit to you, your study will have receive streamlined access to data, deeper data insights, and lead to better performance. By offering unmatched insight into your clinical trial data sources, you can make informed, evidence-based decisions that keep your study on track.
Learn more about how this technology improves the conduct of clinical research by visiting our Why Pharm-Olam page.
It’s important to choose a team that has the right kind of therapeutic experience for your clinical trial. Our teams have executed studies for infectious disease and vaccine treatments across a wide variety of indications:
Prosthetic joint infection
Skin structure infection
Upper respiratory tract infection
Urinary tract infection
Looking for a partner to support your next infectious disease and vaccines clinical trial?
Our team is ready to help. Talk with our experts today.